American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers

doi:10.1200/JCO.2013.50.9257

Practice Guideline

. 2014 Mar 10;32(8):833-40.

doi: 10.1200/JCO.2013.50.9257. Epub 2014 Feb 3.

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers

Karen H Lu¹, Marie E Wood, Molly Daniels, Cathy Burke, James Ford, Noah D Kauff, Wendy Kohlmann, Noralane M Lindor, Therese M Mulvey, Linda Robinson, Wendy S Rubinstein, Elena M Stoffel, Carrie Snyder, Sapna Syngal, Janette K Merrill, Dana Swartzberg Wollins, Kevin S Hughes; American Society of Clinical Oncology

Affiliations

Affiliation

¹ Karen H. Lu, Molly Daniels, and Cathy Burke, MD Anderson Cancer Center, Houston; Linda Robinson, Simmons Comprehensive Cancer Center, Dallas, TX; Marie E. Wood, University of Vermont, Burlington, VT; James Ford, Stanford University Medical Center, Stanford, CA; Noah D. Kauff, Memorial Sloan-Kettering Cancer Center, New York, NY; Wendy Kohlmann, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Noralane M. Lindor, Mayo Clinic, Scottsdale, AZ; Therese M. Mulvey, Southcoast Centers for Cancer Care, Fall River; Sapna Syngal, Dana-Farber Cancer Institute, Brigham and Women's Hospital; Kevin S. Hughes, Avon Comprehensive Breast Evaluation Center, Massachusetts General Hospital, Boston, MA; Wendy Rubinstein, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD; Elena M. Stoffel, University of Michigan, Ann Arbor, MI; Carrie Snyder, Creighton University, Omaha, NE; and Janette K. Merrill and Dana Swartzberg Wollins, American Society of Clinical Oncology, Alexandria, VA.

PMID: 24493721
PMCID: PMC3940540
DOI: 10.1200/JCO.2013.50.9257

Practice Guideline

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers

Karen H Lu et al. J Clin Oncol. 2014.

. 2014 Mar 10;32(8):833-40.

doi: 10.1200/JCO.2013.50.9257. Epub 2014 Feb 3.

Authors

Affiliation

¹ Karen H. Lu, Molly Daniels, and Cathy Burke, MD Anderson Cancer Center, Houston; Linda Robinson, Simmons Comprehensive Cancer Center, Dallas, TX; Marie E. Wood, University of Vermont, Burlington, VT; James Ford, Stanford University Medical Center, Stanford, CA; Noah D. Kauff, Memorial Sloan-Kettering Cancer Center, New York, NY; Wendy Kohlmann, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Noralane M. Lindor, Mayo Clinic, Scottsdale, AZ; Therese M. Mulvey, Southcoast Centers for Cancer Care, Fall River; Sapna Syngal, Dana-Farber Cancer Institute, Brigham and Women's Hospital; Kevin S. Hughes, Avon Comprehensive Breast Evaluation Center, Massachusetts General Hospital, Boston, MA; Wendy Rubinstein, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD; Elena M. Stoffel, University of Michigan, Ann Arbor, MI; Carrie Snyder, Creighton University, Omaha, NE; and Janette K. Merrill and Dana Swartzberg Wollins, American Society of Clinical Oncology, Alexandria, VA.

PMID: 24493721
PMCID: PMC3940540
DOI: 10.1200/JCO.2013.50.9257

No abstract available

PubMed Disclaimer

Conflict of interest statement

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Comment in

Collection and use of family history in oncology clinics.
Hemminki K, Fallah M, Hemminki A. Hemminki K, et al. J Clin Oncol. 2014 Oct 10;32(29):3344-5. doi: 10.1200/JCO.2014.56.4336. Epub 2014 Sep 2. J Clin Oncol. 2014. PMID: 25185094 No abstract available.
Important differences between a triage pedigree and risk assessment.
Larsen Haidle J. Larsen Haidle J. J Clin Oncol. 2014 Oct 10;32(29):3345-6. doi: 10.1200/JCO.2014.56.8378. Epub 2014 Sep 2. J Clin Oncol. 2014. PMID: 25185095 No abstract available.

Cited by

Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters.
Nguyen TNA, Huang PS, Chu PY, Hsieh CH, Wu MH. Nguyen TNA, et al. Cancers (Basel). 2023 Nov 11;15(22):5372. doi: 10.3390/cancers15225372. Cancers (Basel). 2023. PMID: 38001632 Free PMC article. Review.
Developments in Genetics: Better Management of Ovarian Cancer Patients.
Maioru OV, Radoi VE, Coman MC, Hotinceanu IA, Dan A, Eftenoiu AE, Burtavel LM, Bohiltea LC, Severin EM. Maioru OV, et al. Int J Mol Sci. 2023 Nov 5;24(21):15987. doi: 10.3390/ijms242115987. Int J Mol Sci. 2023. PMID: 37958970 Free PMC article. Review.
ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023.
Cufer T, Kosty MP; Curriculum Development Subgroup—ESMO/ASCO Global Curriculum Working Group. Cufer T, et al. JCO Glob Oncol. 2023 Sep;9:e2300277. doi: 10.1200/GO.23.00277. JCO Glob Oncol. 2023. PMID: 37867478 Free PMC article.
Web-based tool for cancer family history collection: A prospective randomized controlled trial.
Frey MK, Ahsan MD, Webster E, Levi SR, Brewer JT, Lin J, Blank SV, Krinsky H, Nchako C, Wolfe I, Thomas C, Christos P, Cantillo E, Chapman-Davis E, Holcomb K, Sharaf RN. Frey MK, et al. Gynecol Oncol. 2023 Jun;173:22-30. doi: 10.1016/j.ygyno.2023.04.001. Epub 2023 Apr 14. Gynecol Oncol. 2023. PMID: 37062188 Free PMC article. Clinical Trial.
Identification of individuals at high-risk for pancreatic cancer using a digital patient-input tool combining family cancer history screening and new-onset diabetes.
Klatte DCF, Clift KE, Mantia SK, Millares L, Hoogenboom SAM, Presutti RJ, Wallace MB. Klatte DCF, et al. Prev Med Rep. 2023 Jan 16;31:102110. doi: 10.1016/j.pmedr.2023.102110. eCollection 2023 Feb. Prev Med Rep. 2023. PMID: 36820377 Free PMC article.

See all "Cited by" articles

References

1. Zon RT, Goss E, Vogel VG, et al. American Society of Clinical Oncology policy statement: The role of the oncologist in cancer prevention and risk assessment. J Clin Oncol. 2009;27:986–993. - PMC - PubMed
1. Statement of the American Society of Clinical Oncology. Genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol. 1996;14:1730–1736. - PubMed
1. American Society of Clinical Oncology policy statement update. Genetic testing for cancer susceptibility. J Clin Oncol. 2003;21:2397–2406. - PubMed
1. Robson ME, Storm CD, Weitzel J, et al. American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2010;28:893–901. - PubMed
1. Wilson BJ, Qureshi N, Santaguida P, et al. Systematic review: Family history in risk assessment for common diseases. Ann Intern Med. 2009;151:878–885. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Zon RT, Goss E, Vogel VG, et al. American Society of Clinical Oncology policy statement: The role of the oncologist in cancer prevention and risk assessment. J Clin Oncol. 2009;27:986–993. - PMC - PubMed

[2] Zon RT, Goss E, Vogel VG, et al. American Society of Clinical Oncology policy statement: The role of the oncologist in cancer prevention and risk assessment. J Clin Oncol. 2009;27:986–993. - PMC - PubMed

[3] Statement of the American Society of Clinical Oncology. Genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol. 1996;14:1730–1736. - PubMed

[4] Statement of the American Society of Clinical Oncology. Genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol. 1996;14:1730–1736. - PubMed

[5] American Society of Clinical Oncology policy statement update. Genetic testing for cancer susceptibility. J Clin Oncol. 2003;21:2397–2406. - PubMed

[6] American Society of Clinical Oncology policy statement update. Genetic testing for cancer susceptibility. J Clin Oncol. 2003;21:2397–2406. - PubMed

[7] Robson ME, Storm CD, Weitzel J, et al. American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2010;28:893–901. - PubMed

[8] Robson ME, Storm CD, Weitzel J, et al. American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2010;28:893–901. - PubMed

[9] Wilson BJ, Qureshi N, Santaguida P, et al. Systematic review: Family history in risk assessment for common diseases. Ann Intern Med. 2009;151:878–885. - PubMed

[10] Wilson BJ, Qureshi N, Santaguida P, et al. Systematic review: Family history in risk assessment for common diseases. Ann Intern Med. 2009;151:878–885. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers

Affiliation

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers

Authors

Affiliation

Conflict of interest statement

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Conflict of interest statement

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical